it is not recommended to take together with medicines that affect the metabolism, cardiovascular system, nervous system or other important functions of the body, because they can interact with it or change its effect
However, policies can vary between organizations and may be updated as new safety data emerges
This article reviews current research, clinical guidance, and practical considerations for patients and healthcare providers
Increased risk of coronary artery disease in Caucasians with extremely low HDL cholesterol due to mutations in ABCA1, APOA1, and LCAT
The physiological changes that produced obesity, including altered appetite regulation, impaired satiety signaling, and metabolic adaptations, do not resolve permanently with weight loss alone